All Stories

  1. Outstanding Reviewers for ChemComm in 2023
  2. Oxime-Conjugated Dendrimers as Therapeutics for Organophosphate Poisoning
  3. Caged Oxime Reactivators Designed for the Light Control of Acetylcholinesterase Reactivation †
  4. Nanomaterial-Enabled Sensors and Therapeutic Platforms for Reactive Organophosphates
  5. Dual acting oximes designed for therapeutic decontamination of reactive organophosphates via catalytic inactivation and acetylcholinesterase reactivation
  6. Activation Strategies in Image-Guided Nanotherapeutic Delivery
  7. Dendrimer nanoreactors as emerging nanotherapeutics for treating reactive organophosphate exposure
  8. Photoactivation Strategies for Therapeutic Release in Nanodelivery Systems
  9. Shielded α-Nucleophile Nanoreactor for Topical Decontamination of Reactive Organophosphate
  10. Multifunctional therapeutic strategy of Ag-synergized dual-modality upconversion nanoparticles to achieve the rapid and sustained cidality of methicillin-resistant Staphylococcus aureus
  11. Spacer-Mediated Control of Coumarin Uncaging for Photocaged Thymidine
  12. Photonanotechnology for Therapeutics and Imaging
  13. Photocleavable linkers
  14. Front Matter
  15. Photocontrolled nanosystems for antibacterial drug delivery
  16. Light sources for photonanotechnology
  17. Photocontrolled nanosystems for antitumor drug delivery
  18. Upconversion nanocrystals for near-infrared-controlled drug delivery
  19. Contributors
  20. Preface
  21. Hydrophilic scaffolds of oxime as the potent catalytic inactivator of reactive organophosphate
  22. Reactivity and mechanism of α-nucleophile scaffolds as catalytic organophosphate scavengers
  23. Discovery of TD-0212, an Orally Active Dual Pharmacology AT1 Antagonist and Neprilysin Inhibitor (ARNI)
  24. Measuring the Adhesion Forces for the Multivalent Binding of Vancomycin-Conjugated Dendrimer to Bacterial Cell-Wall Peptide
  25. Oritavancin Retains a High Affinity for a Vancomycin-Resistant Cell-Wall Precursor via Its Bivalent Motifs of Interaction
  26. Lanthanide-doped core–shell nanoparticles as a multimodality platform for imaging and photodynamic therapy
  27. Photocontrolled Release of Doxorubicin Conjugated through a Thioacetal Photocage in Folate-Targeted Nanodelivery Systems
  28. Ligand Characteristics Important to Avidity Interactions of Multivalent Nanoparticles
  29. Photodynamic Therapy: Efficacy Dependence of Photodynamic Therapy Mediated by Upconversion Nanoparticles: Subcellular Positioning and Irradiation Productivity (Small 13/2017)
  30. Control of an Unusual Photo-Claisen Rearrangement in Coumarin Caged Tamoxifen through an Extended Spacer
  31. Efficacy Dependence of Photodynamic Therapy Mediated by Upconversion Nanoparticles: Subcellular Positioning and Irradiation Productivity
  32. Yolk-structured multifunctional up-conversion nanoparticles for synergistic photodynamic–sonodynamic antibacterial resistance therapy
  33. Riboflavin-Conjugated Multivalent Dendrimer Platform for Cancer-Targeted Drug and Gene Delivery
  34. Inside Cover: A Thioacetal Photocage Designed for Dual Release: Application in the Quantitation of Therapeutic Release by Synchronous Reporter Decaging (ChemBioChem 1/2017)
  35. A Thioacetal Photocage Designed for Dual Release: Application in the Quantitation of Therapeutic Release by Synchronous Reporter Decaging
  36. Mechanistic basis of light induced cytotoxicity of photoactive nanomaterials
  37. Light-controlled active release of photocaged ciprofloxacin for lipopolysaccharide-targeted drug delivery using dendrimer conjugates
  38. Mechanism of Cooperativity and Nonlinear Release Kinetics in Multivalent Dendrimer–Atropine Complexes
  39. Modular Integration of Upconverting Nanocrystal-Dendrimer Composites for Folate Receptor-Specific NIR Imaging and Light-Triggered Drug Release
  40. Mechanisms of Drug Release in Nanotherapeutic Delivery Systems
  41. Force Spectroscopy of Multivalent Binding of Riboflavin-Conjugated Dendrimers to Riboflavin Binding Protein
  42. Mechanisms and Implications of Dual-Acting Methotrexate in Folate-Targeted Nanotherapeutic Delivery
  43. A lipopolysaccharide binding heteromultivalent dendrimer nanoplatform for Gram negative cell targeting
  44. 4-Hydroxytamoxifen probes for light-dependent spatiotemporal control of Cre-ER mediated reporter gene expression
  45. Multivalent Dendrimer Vectors with DNA Intercalation Motifs for Gene Delivery
  46. Poly(amidoamine) Dendrimer–Methotrexate Conjugates: The Mechanism of Interaction with Folate Binding Protein
  47. Evaluating Binding Avidities of Populations of Heterogeneous Multivalent Ligand-Functionalized Nanoparticles
  48. Avidity Mechanism of Dendrimer–Folic Acid Conjugates
  49. Atomic Force Microscopy Probing of Receptor–Nanoparticle Interactions for Riboflavin Receptor Targeted Gold–Dendrimer Nanocomposites
  50. Design and mechanistic investigation of oxime-conjugated PAMAM dendrimers as the catalytic scavenger of reactive organophosphate
  51. An AFM Force Pulling Study of Riboflavin Receptor Targeting Nanoparticles
  52. Avidity Modulation of Folate-Targeted Multivalent Dendrimers for Evaluating Biophysical Models of Cancer Targeting Nanoparticles
  53. DNA Condensation by Partially Acetylated Poly(amido amine) Dendrimers: Effects of Dendrimer Charge Density on Complex Formation
  54. Design and In vitro Validation of Multivalent Dendrimer Methotrexates as a Folate-targeting Anticancer Therapeutic
  55. Paclitaxel-Conjugated PAMAM Dendrimers Adversely Affect Microtubule Structure through Two Independent Modes of Action
  56. Dendrimer-Based Multivalent Vancomycin Nanoplatform for Targeting the Drug-Resistant Bacterial Surface
  57. Synthesis of a photocaged tamoxifen for light-dependent activation of Cre-ER recombinase-driven gene modification
  58. An Atomic Force Microscopy Study of Riboflavin Receptor Targeting Nanoparticles
  59. Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT4 receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation
  60. Polyvalent Dendrimer-Methotrexate as a Folate Receptor-Targeted Cancer Therapeutic
  61. Specific and Cooperative Interactions between Oximes and PAMAM Dendrimers As Demonstrated by 1 H NMR Study
  62. Discovery, oral pharmacokinetics and in vivo efficacy of a highly selective 5-HT4 receptor agonist: Clinical compound TD-2749
  63. Effect of targeted drug delivery with G5-MTX dendrimers on induced T regulatory (iTreg) CD4+ T cells in an inflammatory bowel disease (IBD) colitis model (52.1)
  64. Photochemical release of methotrexate from folate receptor-targeting PAMAM dendrimer nanoconjugate
  65. Thermodynamic Characterization of a Riboflavin‐Dendrimer Platform for Targeted Drug Delivery Applications
  66. Biophysical Characterization of a Riboflavin-Conjugated Dendrimer Platform for Targeted Drug Delivery
  67. A photochemical approach for controlled drug release in targeted drug delivery
  68. Taxol-Conjugated Pamam Dendrimers Utilize Three Modes of Action on Microtubule Structure
  69. Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting
  70. A multivalent approach to the discovery of long-acting β2-adrenoceptor agonists for the treatment of asthma and COPD
  71. Characterizing a Riboflavin-Dendrimer Platform for Targeted Drug Delivery Applications
  72. Specificity and Negative Cooperativity in Dendrimer–Oxime Drug Complexation
  73. Bioanalytical Screening of Riboflavin Antagonists for Targeted Drug Delivery—A Thermodynamic and Kinetic Study
  74. Developing a Synthetic Mimic of Promoter Searching by RNA Polymerase
  75. Characterizing Riboflavin Antagonists for Targeted Drug Delivery Applications
  76. Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted delivery
  77. Light-controlled release of caged doxorubicin from folate receptor-targeting PAMAM dendrimer nanoconjugate
  78. Progress in Cancer Nanotechnology
  79. A Multivalent Approach to the Design and Discovery of Orally Efficacious 5-HT 4 Receptor Agonists
  80. Exploring the Positional Attachment of Glycopeptide/β-lactam Heterodimers
  81. Designing Selective, High Affinity Ligands of 5-HT 1D Receptor by Covalent Dimerization of 5-HT 1F Ligands Derived From 4-Fluoro- N -[3-(1-methyl-4-piperidinyl)-1 H -indol-5-yl]benzamide
  82. Synthetic Multivalent Molecules: Concepts and Biomedical Applications. By Seok-Ki Choi.
  83. Synthetic Multivalent Molecules
  84. Appendix
  85. Frontmatter
  86. Index
  87. Introduction
  88. References
  89. Chemical Synthesis of Multivalent Molecules
  90. Multivalent Molecules Applied to Bacterial Targets
  91. Multivalent Molecules Applied to Cellular Targets
  92. Multivalent Molecules Applied to Viral Targets
  93. A structurally biased combinatorial approach for discovering new anti-picornaviral compounds
  94. ChemInform Abstract: Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors
  95. Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors
  96. Polyvalente Wechselwirkungen in biologischen Systemen: Auswirkungen auf das Design und die Verwendung multivalenter Liganden und Inhibitoren
  97. Polyvalente Wechselwirkungen in biologischen Systemen: Auswirkungen auf das Design und die Verwendung multivalenter Liganden und Inhibitoren
  98. Optically controlled collisions of biological objects
  99. Structure-binding relation of philanthotoxins from nicotinic acetylcholine receptor binding assay
  100. Generation and in Situ Evaluation of Libraries of Poly(acrylic acid) Presenting Sialosides as Side Chains as Polyvalent Inhibitors of Influenza-Mediated Hemagglutination
  101. Optically controlled collisions of biological objects to evaluate potent polyvalent inhibitors of virus-cell adhesion
  102. Monomeric inhibitors of influenza neuraminidase enhance the hemagglutination inhibition activities of polyacrylamides presenting multiple C-sialoside groups
  103. Synthesis of C-5 Analogs of N -Acetylneuraminic Acid via Indium-Mediated Allylation of N-Substituted 2-Amino-2-deoxymannoses
  104. The action of philanthotoxin-343 and photolabile analogues on locust (Schistocerca gregaria) muscle
  105. Labeling studies of photolabile philanthotoxins with nicotinic acetylcholine receptors: mode of interaction between toxin and receptor
  106. Bioorganic studies of transmitter receptors with philanthotoxin analogs
  107. ChemInform Abstract: Synthesis and Assay of Hybrid Analogues of Argiotoxin‐636 and Philanthotoxin‐433: Glutamate Receptor Antagonists
  108. Selective antagonism of native and cloned kainate and NMDA receptors by polyamine-containing toxins.
  109. Synthesis and assay of hybrid analogs of argiotoxin-636 and philanthotoxin-433: glutamate receptor antagonists
  110. ChemInform Abstract: Synthesis of Novel and Photolabile Philanthotoxin Analogs: Glutamate Receptor Antagonists
  111. Synthesis of novel and photolabile philanthotoxin analogs: Glutamate receptor antagonists
  112. Philanthotoxin-433 and Analogs, Noncompetitive Antagonists of Glutamate and Nicotinic Acetylcholine Receptors
  113. Photocontrolled Release of Doxorubicin Conjugated through a Thioacetal Photocage in Folate-Targeted Nanodelivery Systems
  114. Control of an Unusual Photo-Claisen Rearrangement in Coumarin Caged Tamoxifen through an Extended Spacer